Detalhe da pesquisa
1.
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
J Clin Microbiol
; 60(3): e0236221, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170980
2.
Challenges and controversies in childhood tuberculosis.
Lancet
; 394(10202): 967-978, 2019 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31526740
3.
Preventing tuberculosis in children: A global health emergency.
Paediatr Respir Rev
; 36: 44-51, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253128
4.
Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 208(2): 130-131, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276531
5.
Celebrating choice in the care of people living with drug-resistant tuberculosis.
Lancet
; 400(10362): 1489-1491, 2022 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522197
6.
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.
Eur Respir J
; 51(6)2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724920
7.
Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.
N Engl J Med
; 380(22): 2178-2180, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141643
8.
Treating Drug-resistant Tuberculosis Infection: No More Excuses.
Clin Infect Dis
; 72(10): 1716-1718, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266941
9.
Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa".
Eur Respir J
; 56(1)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703820
10.
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
Eur Respir J
; 56(1)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471936
11.
Reducing harm in the treatment of multidrug-resistant tuberculosis.
Lancet
; 392(10150): 797-798, 2018 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215367
12.
Multidrug-resistant tuberculosis.
Nat Rev Dis Primers
; 10(1): 22, 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523140
13.
Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
Lancet
; 390(10098): 934, 2017 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28872029
14.
Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis.
Pathogens
; 12(5)2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37242398
15.
Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household.
Open Forum Infect Dis
; 10(3): ofad087, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36910692
16.
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study.
Lancet Microbe
; 4(7): e506-e515, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295446
17.
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study.
Lancet Microbe
; 4(12): e972-e982, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931638
18.
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.
Lancet Infect Dis
; 22(7): 1042-1051, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512718
19.
Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa.
Trop Med Infect Dis
; 7(2)2022 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202216
20.
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
Lancet Infect Dis
; 22(4): 496-506, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780706